TY  - JOUR

T1  - Real-world (rw) first-line (1L) treatment (tx) patterns and overall survival (OS) in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) and frailty or comorbidities.

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2026.44.7_suppl.666

PY  - 2026/03/01

AU  - Grande E

AU  - Bamias A

AU  - de Wit R

AU  - Hussain SA

AU  - Thibault C

AU  - Kearney M

AU  - Hoffman J

AU  - Morris V

AU  - Chen L

AU  - Roos J

AU  - Hankinson E et al

ED  - 

DO  - DOI: 10.1200/jco.2026.44.7_suppl.666

PB  - American Society of Clinical Oncology (ASCO)

VL  - 44

IS  - 7_suppl

SP  - 666

EP  - 666

Y2  - 2026/04/02

ER  -